Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Epitopes | 2 | 2021 | 4113 | 0.44 | Why? |
| Proteome | 1 | 2021 | 1812 | 0.42 | Why? |
| Hepatitis B virus | 2 | 2019 | 882 | 0.22 | Why? |
| Common Variable Immunodeficiency | 1 | 2020 | 195 | 0.18 | Why? |
| Blood Donors | 2 | 2021 | 2956 | 0.17 | Why? |
| Antibodies, Viral | 9 | 2021 | 51949 | 0.17 | Why? |
| CD4-Positive T-Lymphocytes | 2 | 2021 | 4545 | 0.16 | Why? |
| Immunogenicity, Vaccine | 2 | 2021 | 4624 | 0.15 | Why? |
| Liver Failure, Acute | 1 | 2019 | 279 | 0.15 | Why? |
| T-Lymphocytes | 3 | 2021 | 6670 | 0.14 | Why? |
| Immunoglobulin A | 3 | 2021 | 3567 | 0.14 | Why? |
| Coronaviridae | 1 | 2020 | 923 | 0.14 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2018 | 724 | 0.13 | Why? |
| Neutralization Tests | 3 | 2021 | 6698 | 0.12 | Why? |
| Coronavirus 229E, Human | 1 | 2021 | 1241 | 0.12 | Why? |
| Antibodies, Neutralizing | 5 | 2021 | 25288 | 0.11 | Why? |
| Hepatitis B, Chronic | 1 | 2018 | 616 | 0.11 | Why? |
| Germany | 3 | 2021 | 9196 | 0.11 | Why? |
| Immunoglobulin G | 5 | 2021 | 21571 | 0.11 | Why? |
| Hepatitis B | 1 | 2019 | 888 | 0.10 | Why? |
| Vaccination | 5 | 2021 | 19050 | 0.10 | Why? |
| Dexamethasone | 1 | 2021 | 2055 | 0.10 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Renal Dialysis | 1 | 2021 | 4358 | 0.07 | Why? |
| Kinetics | 2 | 2021 | 3238 | 0.06 | Why? |
| Adult | 9 | 2021 | 244371 | 0.06 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2018 | 5837 | 0.06 | Why? |
| Rh-Hr Blood-Group System | 1 | 2021 | 55 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2020 | 8041 | 0.05 | Why? |
| Berlin | 1 | 2021 | 283 | 0.05 | Why? |
| CD3 Complex | 1 | 2021 | 237 | 0.05 | Why? |
| Immunization, Passive | 3 | 2021 | 10067 | 0.05 | Why? |
| Convalescence | 2 | 2021 | 2829 | 0.05 | Why? |
| Immunity | 2 | 2021 | 2651 | 0.05 | Why? |
| Cross Reactions | 2 | 2021 | 4374 | 0.05 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.05 | Why? |
| Antigen-Antibody Reactions | 1 | 2020 | 616 | 0.05 | Why? |
| Aged | 7 | 2021 | 215776 | 0.04 | Why? |
| Humans | 16 | 2021 | 930598 | 0.04 | Why? |
| Male | 10 | 2021 | 367725 | 0.04 | Why? |
| Genome, Viral | 1 | 2019 | 13157 | 0.04 | Why? |
| Immunodominant Epitopes | 1 | 2021 | 813 | 0.04 | Why? |
| Female | 10 | 2021 | 380317 | 0.04 | Why? |
| Open Reading Frames | 1 | 2021 | 1898 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2020 | 2689 | 0.03 | Why? |
| Cricetinae | 1 | 2020 | 3344 | 0.03 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.03 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.03 | Why? |
| Tissue Donors | 1 | 2021 | 1679 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Peptide Fragments | 1 | 2021 | 2075 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 4 | 2021 | 37182 | 0.03 | Why? |
| Cells, Cultured | 1 | 2021 | 5835 | 0.03 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2020 | 5542 | 0.02 | Why? |
| Long-Term Care | 1 | 2021 | 2047 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2021 | 3444 | 0.02 | Why? |
| Respiratory System | 1 | 2021 | 3213 | 0.02 | Why? |
| Binding Sites | 1 | 2020 | 6201 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Molecular Dynamics Simulation | 1 | 2020 | 4155 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Cell Line | 1 | 2020 | 12040 | 0.02 | Why? |
| Protein Binding | 1 | 2020 | 11430 | 0.02 | Why? |
| Fever | 1 | 2021 | 7795 | 0.02 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2020 | 10998 | 0.01 | Why? |
| Anti-Inflammatory Agents | 1 | 2021 | 6153 | 0.01 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Mice | 1 | 2020 | 21357 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Mutation | 1 | 2019 | 12376 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Prognosis | 1 | 2019 | 32490 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Animals | 1 | 2020 | 78931 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Retrospective Studies | 1 | 2019 | 105322 | 0.01 | Why? |
| Pandemics | 1 | 2020 | 389249 | 0.00 | Why? |
Schwarz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(95)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(191)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_